45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,245
Insurances with rates
23
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-186721 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $131,508 | $13,151 | — | — | 21 |
| RX-108956 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $114,524 | $11,452 | — | — | 21 |
| RX-41815 | NM ISO Y-90 IBRITUMOMAB PER DOSE UP TO 40 MCI | $78,180 | $7,818 | — | — | 12 |
| RX-40840557 | NM ISO Y-90 SIR-SPHERES RESIN MICROSPHERES PER DOSE | $78,180 | $7,818 | — | — | 28 |
| RX-170511 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $75,622 | $7,562 | — | — | 21 |
| RX-184719 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $48,764 | $4,876 | — | — | 21 |
| RX-105644 | CABAZITAXEL 10 MG/ML (FINAL CONC) INTRAVENOUS SOLUTION | $45,632 | $4,563 | — | — | 21 |
| RX-110751 | LEUPROLIDE ACETATE (6 MONTH) 45 MG INTRAMUSCULAR SYRINGE KIT | $41,918 | $4,192 | — | — | 21 |
| RX-111348 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $40,828 | $4,083 | — | — | 21 |
| RX-177050 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION | $39,017 | $3,902 | — | — | 21 |
| RX-182340 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $38,040 | $3,804 | — | — | 21 |
| RX-165100 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $37,005 | $3,700 | — | — | 21 |
| RX-174319 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $35,137 | $3,514 | — | — | 21 |
| RX-170494 | DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION | $34,038 | $3,404 | — | — | 21 |
| RX-185620 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $33,783 | $3,378 | — | — | 21 |
| RX-178799 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $32,773 | $3,277 | — | — | 21 |
| RX-170557 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $32,555 | $3,255 | — | — | 21 |
| RX-126219 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $31,337 | $3,134 | — | — | 21 |
| PX-36009740 | HC Cysto Impl 4 or More | $30,776 | $3,078 | — | — | 12 |
| RX-179479 | PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN | $30,054 | $3,005 | — | — | 21 |
| RX-98451 | NM ISO I-123 IOBENGUANE (MIBG) PER DOSE UP TO 15MCI | $28,872 | $2,887 | — | — | 12 |
| RX-108955 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $28,631 | $2,863 | — | — | 21 |
| RX-21108 | LEUPROLIDE 30 MG (4 MONTH) INTRAMUSCULAR SYRINGE KIT | $27,945 | $2,794 | — | — | 21 |
| RX-40120 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $27,526 | $2,753 | — | — | 12 |
| RX-9002 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $27,281 | $2,728 | — | — | 21 |
| RX-87860 | LANREOTIDE 90 MG/0.3 ML SUBCUTANEOUS SYRINGE | $26,139 | $2,614 | — | — | 21 |
| RX-175622 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $25,903 | $2,590 | — | — | 21 |
| RX-40845011 | TENECTEPLASE IV BOLUS (STROKE) | $25,722 | $2,572 | — | — | 12 |
| RX-172314 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $25,722 | $2,572 | — | — | 12 |
| RX-179410 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION | $25,575 | $2,558 | — | — | 21 |
| RX-171488 | NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION | $25,116 | $2,512 | — | — | 21 |
| PX-33377372 | Complete single session course of cranial lesion surgery using radiation and a machine to deliver ex | $25,011 | $2,501 | — | — | 20 |
| RX-108057 | PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION | $23,588 | $2,359 | — | — | 21 |
| RX-180945 | NM PET ISO F18 FLUOROESTRADIOL (CERIANNA) PER 1 MCI | $22,910 | $2,291 | — | — | 12 |
| RX-131678 | OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE | $21,429 | $2,143 | — | — | 21 |
| RX-116596 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $21,355 | $2,135 | — | — | 21 |
| RX-170401 | FLUCICLOVINE F18 10 MCI (370 MBQ) INTRAVENOUS SOLUTION | $21,017 | $2,102 | — | — | 12 |
| RX-21045 | LEUPROLIDE 22.5 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT | $20,959 | $2,096 | — | — | 21 |
| RX-180504 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $20,756 | $2,076 | — | — | 42 |
| RX-188908 | NM PET ISO F18 FLOTUFOLASTAT GALLIUM (POSLUMA) PER 1 MCI | $20,666 | $2,067 | — | — | 12 |
| RX-120087 | ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION | $20,580 | $2,058 | — | — | 21 |
| RX-169680 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $20,387 | $2,039 | — | — | 21 |
| RX-81696 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $20,221 | $2,022 | — | — | 12 |
| RX-129658 | PEGFILGRASTIM 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUTANEOUS INJECTOR | $19,896 | $1,990 | — | — | 21 |
| SUP-10180 | SPYSCOPE DS II ACC | $19,795 | $1,980 | — | — | 16 |
| RX-91495 | CERTOLIZUMAB PEGOL 400 MG (200 MG X 2 VIALS) SUBCUTANEOUS KIT | $19,528 | $1,953 | — | — | 21 |
| RX-97853 | CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT | $19,528 | $1,953 | — | — | 21 |
| PX-36036482 | HC Endoven Ablti Ther Chem Adhesive 1st Vein | $19,235 | $1,924 | — | — | 12 |
| RX-127559 | IMMUNE GLOB G 40 GRAM/400 ML(10%)-GLY-IGA AVE 46 MCG/ML INJECTION SOLN | $18,997 | $1,900 | — | — | 21 |
| RX-88653 | IXABEPILONE 45 MG INTRAVENOUS SOLUTION | $18,735 | $1,874 | — | — | 21 |
Showing top 50 of 4,245 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.